Worcester Business Journal

November 25, 2019

Issue link: https://nebusinessmedia.uberflip.com/i/1187054

Contents of this Issue

Navigation

Page 15 of 23

16 Worcester Business Journal | November 25, 2019 | wbjournal.com Top biomedical companies Ranked by number of local employees Company Local employees Products Head of company/ Year founded 1 Sanofi Genzyme (a) 15 Pleasant St. Connector, Framingham 01701 508-872-8400 • www.sanofigenzyme.com 1,800 Biotechnology Bill Sibold executive vice president 1981 2 Boston Scientific Corp. 300 Boston Scientific Way, Marlborough 01752 508-683-5670 • www.bostonscientific.com ~1,700 (b) Medical devices Michael F. Mahoney president & CEO 1979 3 Waters Corp. 34 Maple St., Milford 01757 508-482-2000 • www.waters.com 1,506 Analytical science technologies Christopher J. O'Connell chairman, president & CEO 1958 4 Quest Diagnostics Inc. 200 Forest St., Marlborough 01752 866-697-8378 • www.questdiagnostics.com 1,300 Diagnostic information services Steve Rusckowski president & CEO 1967 5 Hologic Inc. 250 Campus Drive, Marlborough 01752 508-263-2900 • www.hologic.com 1,245 (b) Medical devices Stephen P. MacMillan president & CEO 1985 6 Integrated Genetics (LabCorp) 3400 Computer Drive, Westborough 01581 508-898-9001 • www.integratedgenetics.com ~1,000 (c) Healthcare diagnostics David P. King president & CEO 1991 7 AbbVie Inc. 100 Research Drive, Worcester 01605 508-849-2500 • www.abbvie.com 900 Research-driven biopharmaceuticals targeted at immunology, oncology, virology and neuroscience Richard A. Gonzalez chairman & CEO 2013 8 KARL STORZ Endovision Inc. 91 Carpenter Hill Road, Charlton 01507 508-248-9011 • www.karlstorz.com 850 Endoscopes, medical instruments and devices Bruce Watkins general manager 1989 8 Nypro, a Jabil Co. 101 Union St., Clinton 01510 978-365-9721 • www.nypro.com 850 Medical devices Steve Borges executive vice president & CEO Nypro Healthcare 1955 10 GE Healthcare Life Sciences (d) 350 Campus Drive, Marlborough 01752 508-475-2000 • www.gelifesciences.com 835 Contrast agents for diagnostic imaging, basic research of cells and proteins and the technologies that enable large-scale manufacturing of vaccines, biologics, cell and gene therapies Emmanuel Ligner president & CEO 2004 11 Bristol-Myers Squibb Co. 38 Jackson Road, Devens 01434 978-784-6001 • www.bms.com 798 Diversified specialty biopharmaceuticals for oncology, cardiovascular, immunoscience and fibrosis Giovanni Caforio CEO 1858 12 Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough 01752 508-481-6700 • www.sunovion.com 587 Pharmaceuticals Antony Loebel president & CEO 2010 13 Tegra Medical 9 Forge Parkway, Franklin 02038 508-541-4200 • www.tegramedical.com 390 Contract manufacturer of complex components and complete, medical devices J. Mark King president & CEO 2007 14 SMC Ltd. 18 Independence Drive, Devens 01434 978-422-6800 • www.smcltd.com 300 Contract manufacturing for medical and drug delivery devices Brian Payson general manager & VP 1988 15 PerkinElmer Inc. 68 Elm St., Hopkinton 01748 781-663-6900 • www.perkinelmer.com 280 Detection and imaging instruments, assays, software and services Robert Friel chairman & CEO 1937 16 Olympus Surgical Technologies America 136 Turnpike Road, Southborough 01772 508-804-2600 • www.olympus-osta.com 256 Diagnostic and therapeutic endoscopes, advanced energy-based hand instruments, sterile single-use devices and implants for urology, gynecology, ear nose & throat and general surgery Randy Clark group vice president, Medical Systems Tomo Sakurai head of operations, OSTA 2008 Source: Each company via survey. Note: List includes companies in the biotech, medical device, medical equipment and pharmaceutical industries. Hudson, Wisc.-based Phillips-Medisize acquired Clinton's Injectronics Corp. in June 2016; unable to confirm information about the Clinton facility. Wayland's Candela Corp., a subsidiary of Syneron Inc., was acquired by Apax Partners in April 2017; the company has not responded to the survey since 2015. Biocytogen LLC of Worcester and Ayer's Cambrooke Therapeutics declined to participate in the survey. Unable to confirm information for Franklin's Hamilton Storage, Accelovance of Hudson, Marlborough's AngioDynamics, Milford's SeraCare Life Sciences or Holliston's Biostage Inc. (delisted from the NASDAQ in fall 2017) by press time. For the full list, see the digital edition of WBJ's Book of lists. (a) Sanofi Genzyme is the specialty care global business unit of Sanofi; data from 2018 survey. Opened a new manufacturing facility at 8 New York Ave., Framingham in October 2019. (b) Data from 2018 survey (c) Local employee figure falls within a range of 1,000-4,999 according to data published by the Executive Office of Labor and Workforce Development. (d) GE's biopharmaceutical division was sold for $21 billion in February 2019. - Compiled by: Stephanie R. Meagher, smeagher@nebusinessmedia.com Source: Each company via survey. Note: List includes companies in the biotech, medical device, medical equipment and pharmaceutical industries. Hudson, Wisc.-based Phillips-Medisize acquired Clinton's Injectronics Corp. in June 2016; unable to confirm information about the Clinton facility. Wayland's Candela Corp., a subsidiary of Syneron Inc., was acquired by Apax Partners in April 2017; the company has not responded to the survey since 2015. Biocytogen LLC of Worcester and Ayer's Cambrooke Therapeutics declined to participate in the survey. Unable to confirm information for Franklin's Hamilton Storage, Accelovance of Hudson, Marlborough's AngioDynamics, Milford's SeraCare Life Sciences or Holliston's Biostage Inc. (delisted from the NASDAQ in fall 2017) by press time. For the full list, see the digital edition of WBJ's Book of lists. (a) Sanofi Genzyme is the specialty care global business unit of Sanofi; data from 2018 survey. Opened a new manufacturing facility at 8 New York Ave., Framingham in October 2019. (b) Data from 2018 survey (c) Local employee figure falls within a range of 1,000-4,999 according to data published by the Executive Office of Labor and Workforce Development. (d) GE's biopharmaceutical division was sold for $21 billion in February 2019. - Compiled by: Stephanie R. Meagher, smeagher@nebusinessmedia.com LO KING Many of our doctors are welcoming new patients. Meet them at reliantmedicalgroup.org. for a new doctor? Top biomedical companies Ranked by number of local employees F O C U S H E A L T H C A R E

Articles in this issue

Links on this page

Archives of this issue

view archives of Worcester Business Journal - November 25, 2019